REFERENCES
- Dyken P. Subacute sclerosing panencephalitis. Neurol Clin. 1985; 3(1)179–196, [PUBMED], [INFOTRIEVE], [CSA]
- Santoshkumar B, Radhakrishnan K. Substantial spontaneous long-term remission in subacute sclerosing panencephalitis (SSPE). J Neurol Sci. 1998; 154: 83–88, [PUBMED], [INFOTRIEVE], [CSA]
- L, Tuomanen E, Israele V, Rust R, Menkes J H. Infections of the nervous system. Child neurology., J H Menkes, H B Sarnat. Lippincott Williams & Wilkins, Philadelphia 2000; 558–562
- Singer C, Lang A E, Suchowersky O. Adult-onset subacute sclerosing panencephalitis: case reports and review of the literature. Mov Disord. 1997; 12(3)342–353, [PUBMED], [INFOTRIEVE], [CSA]
- Gass J DM. Stereoscopic atlas of macular diseases 4th ed. Mosby Co, St. Louis, MO 1997; 660–662
- Cochereau-Massin I, Gaudric A, Reinert P, et al. Changes in the fundus in subacute sclerosing panencephalitis. Apropos of 23 cases. J Fr Ophtalmol. 1992; 15: 255–261, [PUBMED], [INFOTRIEVE], [CSA]
- Zagami A S, Lethlean A K. Chorioretinitis as a possible very early manifestation of subacute sclerosing panencephalitis. Aust NZ J Med. 1991; 21: 350–352, [CSA]
- Nguyen N Q, Lee A G, McClure C D, Miller G. Subretinal lesions in subacute sclerosing panencephalitis. J AAPOS. 1999; 3: 252–254, [PUBMED], [INFOTRIEVE], [CSA]
- Floegel I, Haas A, El-Shabrawi Y. Acute multifocal placoid pigment epitheliopathy-like lesion as an early presentation of subacute sclerosing panencephalitis. Am J Ophthalmol. 2003; 135: 103–105, [PUBMED], [INFOTRIEVE], [CSA]
- Nasemann J E, Schmid C, Scheider A, Selde K. Outer retinitis as an early symptom of subacute sclerosing panencephalitis. Klin Monatsbl Augenheilkd. 1995; 206: 122–127, [PUBMED], [INFOTRIEVE], [CSA]
- Landers M B, iii, Klinthworth G K. Subacute sclerosing panencephalitis (SSPE); a clinicopathologic study of the retinal lesions. Arch Ophthalmol. 1971; 86: 156–163, [PUBMED], [INFOTRIEVE], [CSA]
- Font R L, Jenis E H, Tuck K D. Measles maculopathy associated with subacute sclerosing panencephalitis: immunofluorescent and immuno-ultrastructural studies. Arch Pathol. 1973; 96: 168–174, [PUBMED], [INFOTRIEVE], [CSA]
- Yalaz K, Anlar B, Oktem F, Aysun S, Ustacelebi S, Gurcay O, Gucuyener K, Renda Y. Intraventricular interferon and oral inosiplex in the treatment of subacute sclerosing panencephalitis. Neurology. 1992; 42: 488–491, [PUBMED], [INFOTRIEVE], [CSA]
- Anlar B, Yalaz K, Öktem F, Kose G. Long term follow-up of patients with subacute sclerosing panencephalitis treated with intraventricular alpha-interferon. Neurology. 1997; 48: 526–528, [PUBMED], [INFOTRIEVE], [CSA]
- Aranson B GW. Interferon beta in multiple sclerosis. Neurology. 1993; 43: 641–643, [CSA]
- Sobczyk W, Pilkowska E, Iwinska Buksowicz B, Milewska D. Selective problems from catamnestic studies of SSPE patients (1980–1989). Neurol Neurochir Pol. 1994; 28(Suppl. 1)67–78, [PUBMED], [INFOTRIEVE], [CSA]
- Dyken P R. Viral disease of the nervous system. Pediatric neurology. Principles and practice, 1., K F Swaiman. CV Mosby, St. Louis, MO 1999; 499–503
- Anlar B, Yalaz K, Kose G, Saygi S. Beta-interferon plus inosiplex in the treatment of subacute sclerosing panencephalitis. J Child Neurol. 1998; 13(11)557–559, [PUBMED], [INFOTRIEVE], [CSA]
- Tomada A, Nomura K, Shiraishi S, Hamada A, Ohmura T, Hosoya M. Trial of intraventricular ribavirin therapy for subacute sclerosing panencephalitis in Japan. Brain Dev. 2003; 27: 514–517, [CSA]
- Gascon G G. Randomized treatment study of inosiplex versus combined inosplex and intraventricular interferon alpha in subacute sclerosing panencephalitis (SSPE): international multicenter study. J Child Neurol. 2003; 18: 819–827, [PUBMED], [INFOTRIEVE], [CSA]
- Gascon G. Subacute sclerosing panencephalitis. Semin Pediatr Neurol. 1996; 3(4)469, [CSA]